At #arvo2022, with colleagues who worked at Spark prior to #Luxturna launch, whi…
[ad_1]
At #arvo2022, with colleagues who worked at Spark prior to #Luxturna launch, which involved novel functional vision #endpoints, complex #genetictesting paradigms, new administration procedures at treatment centers, & unique reimbursement pathways associated with #genetherapy https://t.co/MMo8oZeVD5
[ad_2]
Source by Thomas Ciulla, MD, MBA